A report by The Indianapolis Star indicates the focus of the research collaboration will be on drug use and prescription practices.
Through the five-year research collaboration, the companies will develop and conduct research projects of mutual interest to quicken the timeline from gathering evidence from the population to having the information accessible to clinicians.
“The need has never been greater to translate an ever-increasing amount of complex data into targeted and meaningful information that enables better decision-making by patients, healthcare professionals and the industry,” said Tim Garnett, senior vice president and CMO of Eli Lilly.
More articles on data sharing:
AMIA calls for HIPAA amendments to allow researchers to access data
Colorado payers collaborating to create data-sharing solution
Americans unconcerned about health data privacy, poll shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.